ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

ClinicalTrials.gov ID: NCT06274801

Public ClinicalTrials.gov record NCT06274801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PAH)

Study identification

NCT ID
NCT06274801
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
GB002, Inc.
Industry
Enrollment
316 participants

Conditions and interventions

Interventions

  • Gereic Dry Powder Inhaler Device
  • Seralutinib Drug

Device · Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2, 2024
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Apr 28, 2026

2024 – 2026

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
Valley Advanced Lung Diseases Institute Fresno California 93720
Department of Veterans Affairs Greater Los Angeles Healthcare System Los Angeles California 90073
UC Davis Health Medical Center Sacramento California 95817
Stanford Healthcare Stanford California 94305
University of Florida Health Gainesville Florida 32610
Mayo Clinic Jacksonville Jacksonville Florida 32224
Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead Atlanta Georgia 30309
The Emory Clinic Atlanta Georgia 30322
Northside Hospital - Atlanta Atlanta Georgia 30342
UI Health Hospital Chicago Illinois 60612
University of Kansas Medical Center Kansas City Kansas 66160
Norton Pulmonary Specialists Louisville Kentucky 40202
University of Michigan Ann Arbor Michigan 48109
Washington University School of Medicine St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68198
University of New Mexico Health Sciences Center Albuquerque New Mexico 87131
NYU Langone Health New York New York 10016
University of Rochester Medical Center Rochester New York 14642
UNC Hospitals Chapel Hill North Carolina 27514
University of Cincinnati Medical Center Cincinnati Ohio 45219
INTEGRIS Cardiovascular Physicians Oklahoma City Oklahoma 73112
The Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Temple Heart and Vascular Institute (Outpatient Clinic) Philadelphia Pennsylvania 19140
UPMC Presbyterian Hospital Pittsburgh Pennsylvania 15213
Medical University of South Carolina - Nexus Research Center Charleston South Carolina 29425
UT Southwestern Medical Center Dallas Texas 75390
CHI St. Luke's Health Baylor College of Medicine Medical Center Houston Texas 77030
Houston Methodist Outpatient Center Houston Texas 77030
University of Texas Health Science Center at San Antonio San Antonio Texas 78229
Intermountain Medical Center Murray Utah 84107
University of Utah Hospital Salt Lake City Utah 84132
Inova Fairfax Medical Campus Falls Church Virginia 22042
Pulmonary Associates of Richmond, Inc. Richmond Virginia 23230

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06274801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06274801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →